News & Press

The researchers from the Departments of Chemistry and Biology at the University of Konstanz have gained fundamental new insights into the degradation of the amino acid lysine - carcinogenic oncometabolites as intermediate products.

Konstanz chemist Professor Stefan Mecking awarded funding for innovative refinery concept for microalgae lipids

Chemists in Konstanz inhibit the biosynthesis of a bacterial signal and, as a result, block the infectious properties of Pseudomonas aeruginosa, the most common germ found in health care facilities.

The Baden-Württemberg Foundation supports collaboration between chemists in Konstanz and Pennsylvania (USA) as part of its programme to promote top-level research

Research teams of the University of Konstanz and the Biotechnology Institute Thurgau succeed in analyzing the structure of the protein FAT10 – fundamental research for a potential cancer therapy

Since November last year 10 new fellows joined KoRS-CB.

University of Konstanz biologists decode energy storage mechanisms in diatoms

Wissenschaftlerteam der Universität Konstanz an Beschreibung gegensätzlicher Funktionen des DNA-Reparaturproteins PARP-1 bei Darmkrebs beteiligt.